Papilledema and pseudotumor cerebri

Ophthalmology Clinics of North America

Volumn 14, Issue 1, 2001, Pages 129-147

  Friedman, D I ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; DIURETIC AGENT; FUROSEMIDE;

BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID SHUNTING; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEADACHE; HUMAN; NERVE DECOMPRESSION; OPTIC DISK; PAPILLEDEMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VISUAL ACUITY; VISUAL IMPAIRMENT;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; PAPILLEDEMA; PSEUDOTUMOR CEREBRI;

EID: 0035027821     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (184)

1. Pseudotumor cerebri (toxic effect of the "magic bullet")
2. Colohan ART: Cranial migration of a lumboperitoneal shunt catheter
3. Idiopathic intracranial hypertension, empty sella turcica and polycystic ovary syndromes - A case report
4. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients
5. Vertical ocular motility disturbances in pseudotumor cerebri
6. Complications of growth hormone therapy in children
7. Pseudotumor cerebri as a side effect of uprorelin acetate
8. Pseudotumor cerebri as a complication of amiodarone therapy
9. Benign intracranial hypertension with spinal and radicular pain
10. Congenital anomalies of the optic disc
11. Protracted postsurgical blindness with visual recovery following optic nerve sheath fenestration
12. Magnetic resonance imaging in pseudotumor cerebri
13. Lumboperitoneal shunting for pseudotumor cerebri
14. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism
15. Idiopathic intracranial hypertension and seventh nerve palsy
16. Macular changes in pseudotumor cerebri before and after optic nerve sheath fenestration
17. Dilemma of the swollen optic disc: A fluorescein retinal angiography study
18. Minocycline treatment and pseudotumor cerebri syndrome
19. Intracranial hypertension and papilledema associated with naladixic acid therapy
20. Pseudotumor cerebri: A presenting manifestation of Addison's Disease
21. Magnetic resonance imaging in pseudotumor cerebri
22. Results of optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbitotomy approach
23. Visual loss in pseudotumor cerebri: Follow-up of 57 patients from 5 to 41 years and a profile of 14 patients with permanent severe visual loss
24. The rational management of idiopathic intracranial hypertension
25. Pseudotumor cerebri treated with lumbo-peritoneal shunt
26. Pseudotumor cerebri and cerebral venous hypertension
27. Pseudotumor cerebri associated with cyclosporine use
28. Cerebral venous thrombosis in adults: A study of 40 cases from Saudi Arabia
29. Pseudotumor cerebri and pregnancy
30. Hearing loss as a false localising sign in raised intracranial pressure
31. The incidence of pseudotumor cerebri: Population studies in Iowa and Louisiana
32. Irregular fluctuation of elevated cerebrospinal fluid pressure
33. Lumboperitoneal shunt for the treatment of pseudotumor cerebri
34. Papillophelbitis: Benign retinopathy resembling papilledema or papillitis
35. Benign intracranial hypertension associated with hypervitaminosis A
36. Anatomical aspects of the cerebrospinal fluid
37. Transient blindness after optic nerve sheath fenestration
38. Benign forms of intracranial hypertension - "Toxic" and "otitic" hydrocephalus
39. Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl
40. Empty sella, growth hormone deficiency and pseudotumor cerebri: Effect of initiation, withdrawal and resumption of growth hormone therapy
41. Unusual ocular motility disturbances with increased intracranial pressure
42. Low tyramine diet in the treatment of idiopathic intracranial hypertension: A pilot study
43. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis
44. Swelling of the optic nerve head: A staging scheme
45. Reversible vertical ocular deviations associated with raised intracranial pressure
46. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: Case reports and review
47. MRI of the optic nerve in benign intracranial hypertension
48. Increased brain water self-diffusion in patients with idiopathic intracranial hypertension
49. Intracranial hypertension and tetracycline therapy
50. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study
51. Optic nerve sheath fenestration for pseudotumor cerebri
52. Pediatric pseudotumor cerebri: Descriptive epidemiology
53. Pseudotumor cerebri in systemic lupus erythematosis
54. Benign intracranial hypertension II: Following corticosteroid therapy
55. Benign intracranial hypertension (pseudotumor cerebri)
56. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri
57. Optic disc edema in increased intracranial pressure: II. Early detection with fluorescein fundus angiography and stereoscopic fundus photography
58. Some measurements of the autonomic nervous system influence on the formation of cerebrospinal fluid
59. Retinal nerve fiber layer changes and visual field loss in idiopathic intracranial hypertension
60. 1C receptor mRNA in the adult rat brain
61. Pseudotumor cerebri in SLE
62. The search for causes of pseudotumor cerebri: A preliminary case-control study
63. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension
64. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri
65. Recurrent pseudotumor cerebri in an HIV-positive patient
66. MR of the optic papilla protrusion in patients with high intracranial pressure
67. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)
68. The definition of a reduced CSF absorption syndrome: A reappraisal of benign intracranial pressure and related conditions
69. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension
70. CSF shunting from the cisterna magna: A report of 16 cases
71. Pseudotumor cerebri in Lyme disease: A case report and literature review
72. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies
73. Optic nerve head drusen and pseudotumor cerebri
74. Papilledema with unusual ocular hemorrhages
75. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss
76. Optic nerve sheath decompression: How does it work? Has its time come?
77. Retropharyngeal rhabdomyosarcoma mimicking pseudotumor cerebri
78. Cerebral venography and manometry in idiopathic intracranial hypertension
79. Idiopathic intracranial hypertension: Relationship to depression, anxiety and quality of life
80. Benign intracranial hypertension in an adult after tetracycline therapy
81. Pseudotumor after arteriovenous malformation embolisation
82. Papilledema in 15 renally compromised patients treated with growth hormone
83. Pseudotumour cerebri after varicella
84. Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy
85. Effects of weight loss on the course of idiopathic intracranial hypertension in women
86. Multiple sclerosis and infection from an epidemiologic aspect
87. The epidemiology of neurologic disease
88. Pseudotumor cerebri complicating varicella in a child
89. Pseudotumor cerebri from cranial venous obstruction
90. Drusen of the optic disk, an irregularly dominant hereditary affection
91. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne
92. Optic nerve sheath decompression in pediatric pseudotumor cerebri
93. Bilateral retinal venous caliber decrease following unilateral optic nerve sheath decompression
94. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension
95. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension)
96. Sympathetic nervous control of cerebrospinal fluid production from the choroid plexus
97. Reduced cerebrospinal fluid formation through cholinergic mechanisms
98. Effect of sympathomimetic drugs and corresponding receptor antagonists on the rate of cerebrospinal fluid production
99. Autonomic nerves in the mammalian choroid plexus and their influence of the formation of cerebrospinal fluid
100. Effect of 5-hydroxytriptamine on the rate of cerebrospinal fluid production in rabbit
101. 1C receptors in the production of CSF from the choroid plexus
102. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease
103. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure
104. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents
105. Benign intraranial hypertension in children with growth hormone deficiency treated with growth hormone
106. Idiopathic intracranial hypertension without papilledema
107. Raised intracranial pressure in minimal forms of craniosynostosis
108. Management of visual loss after optic nerve sheath decompression in patient with pseudotumor cerebri
109. Cerebral venous thrombosis occurring during an ectopic pregnancy and complicated by intracranial hypertension
110. Tinnitus from intracranial hypertension
111. Skew deviation in pseudotumor cerebri
112. Bilateral visual loss and simultanagnosia after lumboperitoneal shunt for pseudotumor cerebri
113. Optic nerve decompression improves hemodynamic parameters in papilledema
114. Pseudotumor cerebri: An unusual complication of brachiocephlic vein thrombosis associated with hemodialysis catheters
115. Vitamin A intoxication as a cause of pseudotumor cerebri
116. MR imaging of pseudotumor cerebri
117. Pseudotumor cerebri induced by vitamin A combined with minocycline
118. Benign intracranial hypertension after nalidixic acid overdose in infants
119. Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension
120. Benign intracranial hypertension following corticosteroid withdrawal in childhood
121. Sympathetic nervous control of cerebrospinal fluid production from the choroid plexus
122. The clinical profile of optic neuritis: Experience of the optic neuritis treatment trial
123. Factors affecting visual loss in benign intracranial hypertension
124. The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site
125. Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry
126. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri
127. Intracranial hypertension and HIV associated meningoradiculitis
128. Recurrent neuroretinitis
129. Uber meningitis serosa und verewandte zustande
130. Pseudotumor cerebri: Incidence and pattern in Northeastern Libya
131. Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study
132. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism
133. Intracranial hypertension and migraine
134. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles
135. Cerebrospinal fluid diversion procedures for pseudotumor cerebri
136. The minor symptoms of increased intracranial pressure: 101 patients with benign intracranial hypertension
137. Visual outcome in a prospective study of idiopathic intracranial hypertension
138. Pseudotumor cerebri: Clinical profile and visual outcome in 63 patients
139. Transient visual obscurations with elevated optic discs
140. Brain swelling of unknown cause
141. Why does tonsillar herniation not occur in idiopathic intracranial hypertension?
142. Pseudotumor cerebri secondary to lithium carbonate
143. Benign intracranial hypertension in an HIV-infected patient: Headache as the only presenting sign
144. Idiopathic intracranial hypertension in children and adolescents
145. Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension
146. Idiopathic intracranial hypertension and facial diplegia
147. All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumor cerebri
148. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri
149. Surgical management of pseudotumor cerebri in pregnancy: Case report
150. Pseudotumor cerebri and hypercalcemia resulting from vitamin A toxicity
151. Ultrasonography of the optic nerves: Clinical application in children with pseudotumor cerebri
152. Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging
153. Otologic manifestations of benign intracranial hypertension syndrome: Diagnosis and management
154. Otologic symptoms and findings of the pseudotumor cerebri syndrome: A preliminary report
155. An unusual presentation of pseudotumor cerebri
156. Increased brain water content in pseudotumour cerebri measured by magnetic imaging of the brain water self diffusion
157. Cerebrospinal fluid vasopressin and increased intracranial pressure
158. Cerebrospinal fluid vasopressin in benign intracranial hypertension
159. Pseudotumor cerebri caused by a synthetic vitamin A preparation
160. Benign intracranial hypertension without papilledema: Role of 24-hour cerebrospinal fluid pressure monitoring in diagnosis and management
161. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri
162. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression
163. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri
164. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity
165. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension
166. Pseudotumor cerebri and Turner syndrome
167. Abnormal regulation of antidiuretic hormone in idiopathic edema
168. Treatment of pseudotumor cerebri with Diamox (acetazolamide)
169. Quantitative evaluation of papilledema in pseudotumor
170. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri
171. All-trans-retinoic acid and pseudotumor cerebri
172. Pseudotumor cerebri associated with prolonged corticosteroid therapy
173. Idiopathic intracranial hypertension: Lack of histologic evidence for cerebral edema
174. Visual loss in pseudotumor cerebri: Incidence and defects related to visual field strategy
175. Idiopathic intracranial hypertension (pseudotumor cerebri): A prospective study of 50 patients
176. Symptoms and disease associations in pseudotumor cerebri: A case-control study
177. Asymmetric papilledema in idiopathic intracranial hypertension: Prospective interocular comparison of sensory visual function
178. Tetracycline and benign intracranial hypertension: Report of five cases
179. Idiopathic intracranial hypertension without papilledema: A case-control study in a headache center
180. Does optic disc appearance distinguish ischemic optic neuropathy from optic neuritis?
181. Computed tomography in benign intracranial hypertension
182. Disk edema in an overweight woman (clinical conference)
183. Serious adverse events in Nor-plant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system